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Intra-individual variability of response times (RTisv) is considered as potential endophe-
notype for attentional deficit/hyperactivity disorder (ADHD). Traditional methods for esti-
mating RTisv lose information regarding response times (RTs) distribution along the task,
with eventual effects on statistical power. Ex-Gaussian analysis captures the dynamic
nature of RTisv, estimating normal and exponential components for RT distribution, with
specific phenomenological correlates. Here, we applied ex-Gaussian analysis to explore
whether intra-individual variability of RTs agrees with criteria proposed by Gottesman and
Gould for endophenotypes. Specifically, we evaluated if normal and/or exponential com-
ponents of RTs may (a) present the stair-like distribution expected for endophenotypes
(ADHD> siblings> typically developing children (TD) without familiar history of ADHD) and
(b) represent a phenotypic correlate for previously described genetic risk variants. This is
a pilot study including 55 subjects (20 ADHD-discordant sibling-pairs and 15 TD children),
all aged between 8 and 13 years. Participants resolved a visual Go/Nogo with 10% Nogo
probability. Ex-Gaussian distributions were fitted to individual RT data and compared among
the three samples. In order to test whether intra-individual variability may represent a cor-
relate for previously described genetic risk variants, VNTRs at DRD4 and SLC6A3 were
identified in all sibling-pairs following standard protocols. Groups were compared adjust-
ing independent general linear models for the exponential and normal components from the
ex-Gaussian analysis. Identified trends were confirmed by the non-parametric Jonckheere–
Terpstra test. Stair-like distributions were observed for µ (p=0.036) and σ (p=0.009). An
additional “DRD4-genotype”×“clinical status” interaction was present for τ (p=0.014)
reflecting a possible severity factor. Thus, normal and exponential RTisv components are
suitable as ADHD endophenotypes.
Keywords: ex-Gaussian analysis, ADHD, intra-individual variability, endophenotypes, response time
INTRODUCTION
Symptom-based diagnostic systems such as the current versions of
the Diagnostic and Statistical Manual of Mental Disorders (DSM)
(1) and the International Classification of Diseases (ICD) (2) have
proved to be useful in the clinical approach to the neuropsychi-
atric patient and in epidemiological settings. Notwithstanding, in
opinion of some authors, their massive utilization in molecular-
genetic studies has probably hampered (or even obstructed) the
identification of susceptibility genes for neuropsychiatric dis-
orders, due to the inherent multidimensionality of phenotypes
defined by them (3). This multidimensionality probably hides
genetic heterogeneity, non-genetic phenocopies, and complex net-
works of gene–gene and gene–environment interactions, among
other confounding phenomena, lowering the statistical power of
association studies (3–5).
Taking this into account, it has been proposed to replace
symptom-based phenotypes by quantifiable markers of liability
or “risk” for a specific disorder (4). These markers, generically
called “endophenotypes” constitute a more “direct” expression
of the gene effect, since they conceptually lie between the gene
and the disorder and – in consequence – are influenced by fewer
genetic and environmental variables than the disorder itself. In
addition to their potential role improving the statistical power of
molecular-genetic studies, endophenotypes should be a valuable
tool when studying how the already-known genetic risk vari-
ants are related to the neurobiological and neuro-physiological
phenotypes that underlie psychiatric disorders, which could be
the first step to elucidate the specific domains of brain func-
tion influenced by these variants. This kind of approach has
been successfully applied, for example, in the functional char-
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acterization of risk genetic variants for psychotic and affective
disorders (6–8).
In the last few years, researchers have started to explore
the potential of some neuro-cognitive and electrophysiolog-
ical/radiological markers as endophenotypes for attentional
deficit/hyperactivity disorder (ADHD). Among them, intra-
individual variability [defined as short-term changes in behavior
that are signed as moment-to-moment fluctuations in task per-
formance (9, 10)] seems to be especially promising. Elevated
intra-individual variability of the response times (RTisv) in ADHD
patients is one of the most consistent findings across the ADHD
literature and has been documented in task assessing working
memory (11), attention (12, 13), inhibitory control (12, 14), and
choice discrimination (15). Interestingly, the magnitude of the
between-group differences reported tends to be larger than most
other neuropsychological parameters studied to the date (16).
Additionally, intra-individual variability is in close agreement with
some of the criteria proposed by Gottesman and Gould to facili-
tate the exclusion of spurious endophenotypes and to increase the
likelihood of identifying stronger associations with genetic factors
(4, 17). In this context, it is worth to mention two important lines
of evidence: (1) studies showing that affected relatives of ADHD
children present greater intra-individual variability compared to
controls (18, 19) and (2) studies supporting the heritability of
intra-individual variability (15, 18, 20).
Traditionally, intra-individual variability has been estimated
by collapsing responses across the entire time interval of the task,
resulting in a single point parameter such as the standard devia-
tion of the response time (RTSD) or the coefficient of variation
of the response time (RTCV), which should capture and represent
how data spread around the mean value. This method implies to
lose a significant amount of specific information regarding the
distribution of response times (RTs) along the task, with eventual
effects on statistical power when comparing RTisv among clinical
groups. Particularly, this method does not recognize the asymmet-
rical positive skew that occasional lapses in attention are expected
to produce in the RTs distributions (21).
During the last decade, the field has moved toward new sta-
tistical approaches aiming to obtain more complete and specific
characterizations of the RTisv. Among these approaches, the ex-
Gaussian analysis on the RTs has provided enlightening results
regarding the dynamic nature of intra-individual variability in
ADHD. Basically, the ex-Gaussian analysis is based on the convo-
lution of an exponential and a Gaussian function, obtaining three
parameters: µ (mu), corresponding to the mean of the normal
component, σ (sigma), corresponding to the SD of the normal
component, and τ (tau), which describes the mean of the expo-
nential component. When fitting ex-Gaussian distributions to RT
data, greater values for τ indicate a higher frequency of excessively
long RTs (22). In general, most of the studies that have applied
ex-Gaussian analysis on RT data from ADHD patients showed
elevation of τ component in the ADHD group (11, 22–27). This
finding is consistent with lapses in attention, due to a defective
effort control mechanisms (22).
In this work, we hypothesize that RTisv – expressed as the τ
and σ components of the ex-Gaussian distribution of RTs – may
be a potential endophenotype for ADHD. In order to address this
hypothesis, we first explored whether healthy siblings of ADHD
patients may present intermediate values of intra-individual vari-
ability in front of a motor inhibition task (Go/NoGO) when
compared to ADHD patients and typically developing children
(TD) without family history of ADHD, and so that, whether
intra-individual variability may follow the hypothetical distribu-
tion postulated for endophenotypes. As a second step, we explored
whether RTisv may represent a phenotypic correlate for previously
described genetic risk variants for ADHD in the genes encoding
for the dopaminergic receptor D4 (DRD4) and for the dopaminer-
gic transporter 1 (SLC6A3/DAT1). We choose the aforementioned
genetic risk variants based on previous evidence suggesting that
RTisv may be associated to dopamine dysfunction (28–30).
To the best of our knowledge, this is the first study apply-
ing the ex-Gaussian approach to simultaneously characterize the
performance of ADHD patients, their asymptomatic first degree
relatives, and TD without family history of ADHD. Additionally,
after an exhaustive search, we did not find other studies applying
ex-Gaussian analysis in order to evaluate intra-individual vari-
ability as a phenotypic correlate to genetic variants in DRD4 and
SLC6A3/DAT1 genes, which has been previously linked to ADHD.
MATERIALS AND METHODS
PARTICIPANTS
In order to evaluate eventual differences in regards to the RT
distribution observed among ADHD patients, their non-affected
siblings, and TD without family history of ADHD, we eval-
uated a total of 55 subjects, corresponding to 20 discordant
sibling-pairs and 15 unaffected children from the general pop-
ulation. Sibling-pairs were originally recruited as part of a par-
allel genetic association study started in 2003 (31). This study
included families from the Great Santiago Area, referred from gen-
eral psychiatric and neurological outpatient services directed to
medium-income population. Unaffected children without fam-
ily history of ADHD were recruited from a medium-income
school from the same socio-economical and geographical area.
Cases and controls belong to a narrow age-range (ranged between
8 and 13 years) in order to avoid age-confounding effects on
performance/neurobehavioral measurements. Groups were com-
parable by age distribution (ADHD group: mean= 11.2 years,
SD= 2.47; sibs group: mean= 11 years, SD= 2.35; unaffected
children from general population: mean= 11.6 years, SD= 0.9
F = 0.25; p= 0.77) and gender distribution [ADHD group: 17
boys and 3 girls; sibs group: 13 boys and 7 girls; unaffected children
from general population: 9 boys and 6 girlsχ2(2)= 3.1; p= 0.21].
Inclusion criteria for ADHD children were as follows: ADHD
combined subtype according to DSM (32), age between 8 and
13 years, having at least one unaffected sibling in the same range
of age and good response to stimulant medication. We included
the latest criteria in order to reduce clinical heterogeneity in our
size-restricted sample. Operationally, we defined “good response
to medication” as a clinically significant improvement in symp-
tomatology reported by parents in an interview with a compe-
tent specialist and documented as at least 20% reduction in the
Conners’ Abbreviated Parent–Teacher Questionnaire for ADHD
symptoms (33). All patients included in this study were treated
with d-amphetamine or methylphenidate, both in doses ranging
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10–30 mg/day. A wash-out period of 24 h free of medication was
required before the neuropsychological assessment.
In the case of the groups composed by non-affected siblings
and TD from the general population, inclusion criteria were age
between 8 and 13 years old and absence of ADHD or any other psy-
chiatric morbidity according to DSM-IV criteria. Additionally, a
negative familiar history of ADHD was required in the TD group.
Familiar history of ADHD was explored in first degree relatives
(siblings and parents) of TD participants by means of a semi-
structured interview assessing presence/absence of DSM-IV crite-
ria during childhood. Children with neurological deficit at physical
examination and/or abnormal baseline electroencephalography
(EEG) were excluded from the study. All aforementioned inclu-
sion/exclusion criteria were assessed according to current ADHD
diagnosis guidelines by a competent specialist (child psychologist
or child neurologist).
We only included ADHD patients and their unaffected siblings
for genotyping analysis. This design was chosen in order to con-
trol for an eventual population stratification effect. As additional
advantage, discordant sibling-pairs share most of the psychosocial
and familial factors that might interact with a potential genetic
predisposition. Thus, for the genetic part of the study, 40 par-
ticipants (corresponding to 20 siblings-pairs) were assigned to
“Risk”or“Non-Risk”genotype groups accordingly with the criteria
described in Section “Group Comparisons.”
GENOTYPING
Genomic DNA was isolated from peripheral blood lymphocytes
by standard methods and amplified by polymerase chain reac-
tion (PCR) to identify the VNTR of the DRD4 and SLC6A3 loci
according to the protocols described by Lichter et al. (34) and by
Cook et al. (35), respectively. PCR products were visualized by
electrophoresis in 3% agarose gels. Details on the PCR primers
sequences have been previously reported by our group (36).
TASK AND PROCEDURES
Details on the Go–NoGo task performed in this study have been
previously reported by our group (36). Briefly, all participants
responded to an 8 min long Go–NoGo Task with a Go:NoGo rate
of 9:1. Stimuli corresponded to green (Go) and red (NoGo) circles
of 2 cm in diameter presented at the center of a black screen during
300 ms, with an inter-trial period of 1,000 ms. A pseudorandom
process ensured that at least six Go stimuli were presented before
each NoGo stimulus. The total task comprised the presentation
of 360 Go and 40 NoGo stimuli. The instruction was to click in
a console as fast as possible, with the dominant hand, after every
Go stimulus, but to inhibit the response in front of NoGo stimuli.
A treatment wash-out period of 24 h was required in all ADHD
patients previous to task performance. No additional tasks or pro-
cedures were performed in the same session. No exclusions due to
task non-compliance were registered.
DATA ANALYSIS
Data treatment for ex-Gaussian analysis
Data corresponding to the response time (RT) in front of all Go
stimuli were obtained from each subject. Only correct responses
were computed in order to determine the parameters of the
ex-Gaussian distribution of RT, according to the data-analysis
protocol originally described by Leth-Stevenson et al. (22). Addi-
tionally, any single RT of <100 ms was considered as accidental key
press and was excluded. Ex-Gaussian distributions were fitted to
RT data using the R statistical package (37), and µ, σ, and τ para-
meters were computed for each participant. The number of RT
observations used for each ex-Gaussian fit depended on the accu-
racy of responding (mean= 287 trials, range= 97–357). Finally, in
order to assess the Goodness-of-fit of the ex-Gaussian models, the
empirical distribution for each child was compared to a random
ex-Gaussian distribution using the values for µ, σ, and τ adjusted
for the same subject. Comparison was performed by means of the
Kolmogorov–Smirnov Test. There were no significant differences
between empirical and ex-Gaussian distributions for any one of
the analyzed subjects.
Group comparisons
In order to compare the characteristics of ex-Gaussian distribu-
tions among ADHD children, their non-affected sibs, and TD from
the general population (TD), we adjusted independent general lin-
ear models for µ, σ, and τ, using age and sex as co-variates and
“clinical group” (ADHD, non-affected sib, or TD) as an ordinal
variable, with ADHD as the highest ordinal value and TD as the
lowest. Additionally, we confirmed the statistical significance of
the detected trends by means of the non-parametric Jonckheere–
Terpstra test to evaluate trend in the data (e.g., ADHA> non-
affected sibs>TD). Significance was defined as alpha= 0.05. For
multiple comparisons, p-values after post hoc analysis are reported.
When comparing the characteristics of the ex-Gaussian distri-
butions regarding to the presence/absence of genetic risk variants
previously linked to ADHD in the DRD4 and SCL6A3 genes, on the
other hand, we applied three consecutive approaches. First, even-
tual differences inµ,σ, and τ between the genetic risk and non-risk
groups were preliminary explored by means of non-parametrical
methods (Wilcoxon Rank Test). In a second step, significance levels
were adjusted by age, sex, and clinical status by means of gen-
eral linear models. Finally, the effect of an interaction between
the “clinical status (presence/absence of ADHD) and genotype
group (risk/control) was explored by general linear models for
µ, σ, and τ, with the independent variables “genetic risk group”
(risk versus control group), age, sex, clinical status, and “genetic
risk group× clinical status” interaction. As mentioned above, in
order to control for population stratification, only sib-pairs were
included for genetic analysis.
“Genetic risk groups” were defined as follows: (a) For DRD4;
the “control” or “non-risk” group was comprised by homozygous
for the DRD4 4-repeat allele. A total of 22 subjects were assigned to
this group and 9 of them were ADHD patients. The “risk” group,
on the other hand, was constituted by carriers of at least one copy
of alleles 7R (n= 11; 3 of them in homozygous state) or 2R (n= 7;
two of them in homozygous state). This group included 18 sub-
jects and 11 subjects presented ADHD among them. There was no
association between allele possession for Exon 3 VNTR of DRD4
and clinical status [χ2 (1)= 0.9, p= 0.34]. We chose to include
carriers of the 7R and 2R alleles in the “risk group” based on pre-
vious reports of association between ADHD and these variants in
different populations (38–40). Additionally, some in vitro studies
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have suggested that receptors encoded by 2R and 7R alleles medi-
ate a reduced response to dopamine in comparison with the 4R
allele (41). (b) For SLC6A3; the “risk group” were comprised by
homozygous for 10R (n= 24; 13 of them were ADHD patients)
and the “control” or “non-risk” was constituted by subjects with
any other genotype (n= 15; 6of them were ADHD patients). The
latter group comprised 14 participants with 9R/10R genotype
and 1 homozygous for the 9R allele. There was no association
between allele possession for 3′UTR VNTR of SLC6A3 and clinical
diagnosis of ADHD, χ2(1)= 0.28, p= 0.59.
ETHICAL ISSUES
All procedures performed as part of this study were approved by
the Ethics Committee of the Pontificia Universidad Catolica de
Chile. The study was fully explained to children and their parents,
and they both agreed to participate by signing written consent
forms.
RESULTS
COMPARISON OF EX-GAUSSIAN DISTRIBUTIONS AMONG ADHD
CHILDREN, THEIR NON-AFFECTED SIBS, AND TD FROM THE GENERAL
POPULATION
Figure 1 shows the graphical representation and values for µ, σ,
and τ when adjusting ex-Gaussian distributions to the RT data
from ADHD patients (solid gray line), non-affected sibs (dotted
line), and TD without family history of ADHD (solid black line).
In order to statistically explore eventual differences among these
groups, we performed linear models for the aforementioned para-
meters, with clinical group as the ordinal variable. Results from
this analysis are summarized in Table 1. There was a statistically
significant effect of the independent variable “clinical group” on
the parameters µ (corresponding to the mean of the Gauss-
ian/normal component of the distribution; p-value= 0.015).
Since models were adjusted with ADHD as the highest ordinal
value and TD as the lowest, we can assume that µ presented with
the stair-like distribution typically expected for endophenotypes.
A similar interesting trend was observed for σ (corresponding
to the SD of the Gaussian/normal component), although it did
not reach statistical significance after controlling for age and sex
(p-value= 0.052). We did not find a statistically significant effect
for “clinical group in the models adjusted for τ. Similar results
were obtained using Jonckheere–Terpstra test to evaluate the trend
ADHD> non-affected sibs>TD (σ: JP= 587, p-value= 0.009,
predictive strength r = 0.35; µ: JP= 559, p-value= 0.0358, pre-
dictive strength r = 0.36; τ: JP= 523, p-value= 0.13).
COMPARISON OF EX-GAUSSIAN DISTRIBUTIONS REGARDING TO THE
PRESENCE/ABSENCE OF GENETIC VARIANTS PREVIOUSLY LINKED TO
ADHD IN THE DRD4 AND SCL6A3 GENES
Figure 2 shows the RT distributions obtained when we clas-
sified and analyzed the subjects in regards to their “genotype
group” for DRD4 (2A) and SCL6A3 (2B). In the case of DRD4,
subjects were classified depending on the presence/absence of
VNTR variants previously linked to ADHD in the exon III of
DRD4, with carriers of at least one copy of the 7R or 2R allele
considered as the risk group and homozygous for 4R as the
controls/non-risk group. The ex-Gaussian distribution adjusted
among subjects from the genetic risk group is more skewed than
the ex-Gaussian distribution for DRD4-4R homozygous, which
is expressed as a bigger value for τ (unadjusted p= 0.013; see
FIGURE 1 | Ex-Gaussian distributions for response times in ADHD children, their unaffected sibs, and typically developing children without family
history of ADHD. Left side: RT density fitted to ex-Gaussian distributions. Right side: µ (mu), σ (sigma), and τ (tau) components in the three studied groups;
bars represent SE for the media.
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Table 1 | Summary of estimated effects in general linear models
adjusted for mu, sigma, and tau parameters.
Model
for. . .
Independent
variable
Estimated
effect
SE t Effect-size r p-value
µ Clinical group 19.09 7.61 2.5 0.33 0.015
Age −6.96 2.88 −2.41 0.31 0.019
Sex −28.82 13.28 −2.16 0.28 0.035
σ Clinical group 6.33 3.19 1.99 0.26 0.052
Age −3.16 1.21 −2.61 0.34 0.011
sex −9.32 5.56 −1.65 – 0.1
τ Clinical group 3.67 7.74 0.52 – 0.6
Age −7.45 2.93 −2.5 0.33 0.015
sex −2.8 13.5 −0.21 – 0.83
Table 2 for a summary of comparisons between DRD4/SCL6A3
genotype groups). Interestingly, linear models demonstrated a
statistically significant effect of the “genotype group”×“clinical
status” interaction exclusively on τ (p-value= 0.014; see Table 3
for a summary of interaction models). This interaction reflects
a greater τ among ADHD subjects carrying DRD4-risk alleles in
comparison to DRD4-4R homozygous (Kruskal–Wallis rank sum
test, χ2= 0.9562, df= 1, p-value= 0.01467, effect-size r = 0.44,
and post hoc p-value: 0.03196; see Figure 3). In the case of SCL6A3,
on the other hand, we did not observe any significant effect of
genotype on any of the ex-Gaussian parameters analyzed (see
Figure 2; Table 2).
DISCUSSION
In the present study, we hypothesized that RTisv, assessed by means
of the ex-Gaussian approach, is suitable as an endophenotype
for ADHD. The principal aim for the first part of the study was
to explore whether any of the parameters characterizing the ex-
Gaussian curves fitted for ADHD patients, their healthy siblings,
and/or TD children without family history of ADHD, present the
“stair-like distribution” expected for an ADHD endophenotype.
In the second part, we intended to explore if the parameters
characterizing the ex-Gaussian distribution of RTs may corre-
spond to phenotypic correlates for genetic variants in DRD4 and
SCL6A3/DAT1, which have been previously linked to ADHD.
From a phenomenological perspective, ex-Gaussian analysis is
able to distinguish whether differences in group performances
obey to (a) a generalized slowing down of the responses times
(reflected at the µ component), (b) an increased variability
throughout the complete distribution (reflected at the σ compo-
nent), or (c) an increased number of abnormally slow responses
(reflected at the τ component). The aforementioned distinction
could be mechanistically relevant, since it has been suggested
that larger τ values may reflect inconsistent effort and fluctua-
tions in attention (attentional lapses), while larger σ components
may reflect deficits in motor timing and/or impaired response
preparation (22, 25). Notwithstanding the potential enclosed in
the aforementioned fine-grained analysis, to date, only few stud-
ies have applied this approach to explore the characteristics of
responses of ADHD children. The majority of these studies have
FIGURE 2 | Ex-Gaussian distributions for response times according to
the presence/absence of previously described genetic risk variants for
(A) DRD4 and (B) SCL6A3/DAT1. Black line: absence of risk alleles; gray
line: presence of at least one risk allele (for a detailed description on group
assignment criteria, please refer to Sections “Materials and Methods,” and
Sections “Group Comparisons”).
found that τ values (representing the positive skew of the RT dis-
tribution) present the highest association with ADHD in tasks
requiring limited executive control, while σ became importantly
correlated to ADHD when analyzing data from tasks requiring
high executive/inhibition control (11, 22–24, 26, 27). Interest-
ingly, the characteristics of the RT ex-Gaussian distribution among
ADHD patients seems to be dependent on the task executive
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Table 2 | Ex-Gaussian parameters in subjects presenting “risk” versus
subjects presenting “non-risk” alleles for DRD4 and SCL6A3/DAT1
genes.
Gene Parameter
(ms)
Risk
group
Non-risk
group
Unadjusted
p-valuea
Adjusted
p-valueb
DRD4 µ 212.2 209.1 0.96 0.56
σ 52.3 47.3 0.24 0.94
τ 122.7 83.2 0.013* 0.14
SCL6A3/DAT1 µ 214.8 201.8 0.48
σ 51.2 47.2 0.92
τ 97.3 117.2 0.26
*Indicates a significance level of 0.05 or less.
aUnadjusted p-value was obtained by means of Wilcoxon sum rank test.
bPresented p-values are adjusted by age, sex, and clinical status (ADHD, healthy
sibs, and/or TD children).
Table 3 | Estimated effects for all co-variates included in the linear
regression models adjusted for µ, σ, and τ.
Model
for. . .
Independent
variable
Estimated
effect
SE p-value Effect-size, r
µ Genotype −23.75 21.98 0.29
Clinical status 11.52 22.45 0.61
Age −5.73 3.81 0.17
Sex −19.73 20.23 0.34
Genotype× clinical
status
24.97 28.76 0.39
σ Genotype −6.17 10.61 0.56
Clinical status 1.5 10.83 0.89
Age −3.35 1.84 0.07
Sex −9.04 9.76 0.36
Genotype× clinical
status
11.66 13.87 0.4
τ Genotype −11.87 16.01 0.47
Clinical status 4.78 16.36 0.77
Age −5.79 2.78 0.05* 0.34
Sex −26.21 14.74 0.09
Genotype× clinical
status
54.71 20.96 0.015* 0.41
*Indicates a significance level of 0.05 or less.
control requirements,by one hand,and on the task duration,by the
other hand, since some studies applying shorter tasks (3–7 min)
have failed to find higher τ component on the RT data of ADHD
patients. In the same line, the duration of the inter-stimulus inter-
val can change the cognitive process measure in the Go/No-Go task
(42). A recent meta-analysis shows that long inter-stimuli intervals
are more sensitive to induce low inattentive responses (43). Thus,
these findings suggest that both, the rate of stimuli presentation
and the duration of the task, influence the amount of low RTs
generated by attentional lapses.
FIGURE 3 | Differential effect of DRD4 genotype on τ (tau) among
ADHD children versus their asymptomatic siblings.
The Go–NoGo task used in this study demands high levels of
executive/inhibition control due to extended task duration (about
8 min), low probability for the NoGo stimuli (10%), and shot
inter-stimuli interval (1000 ms). In these conditions, the µ and
σ components obtained after fitting ex-Gaussian curves on the
RT data from ADHD patients, healthy siblings, and TD children
without family history of ADHD, showed the stair-like distribu-
tion expected for endophenotypes. This finding suggests that not
only ADHD children but also ADHD healthy relatives (or at least a
subpopulation of them) may present alterations in response prepa-
ration and motor timing. By contrast, our experimental conditions
are not particularly conducive to the appearance of attentional
lapses. Hence, it was expected that we failed to find the aforemen-
tioned distribution in the case of τ component, due to our short
inter-trial periods. Nonetheless, the second part of our analysis
showed a statistically significant effect of the“genotype”×“clinical
status” interaction for DRD4 on τ (p-value= 0.014). This result
suggests that – in the context of a relatively long and high demand-
ing inhibition task – attentional lapses may be predominately
expressed on those ADHD patients carrying at least one copy of
the 7R or 2R VNTR variants of DRD4. This finding is in accor-
dance with other works, which associate DRD4 with severity of
ADHD symptoms of impulsivity (44) and inattention (45). Thus,
the presence of the risk alleles of DRD4 could reflect an even-
tual severity mark within the ADHD group that requires further
study.
Although promising, our results require further analysis and
replication. Our small sample size importantly limits the statistical
power of the present study. Our inclusion criteria limit the gener-
alization of our results only to patients presenting good response
to stimulant medication.
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CONCLUSION
Together, our results suggest that intra-individual variability is
suitable as an endophenotype for ADHD. Interestingly, under our
conditions of high requirements of executive/inhibitory control,
only the σ component of variability presented the theoretical
“stair-like distribution” for endophenotypes, while only τ (tau)
seemed to be affected by the DRD4-genotype. Overall, our results
emphasize the advantages of introducing new statistical methods
oriented to reach a dynamic and fine-grain characterization of
performance measures obtained from well-validated tasks in the
analysis of new candidate-endophenotypes in psychiatric disor-
ders. New studies are needed in order to confirm our results under
different attention and inhibitory loads.
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